Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Disposition to Issuer of 383,314 CPRX shares, $12.07M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to Issuer | 383,314 | $12.07M |
| Dec 30, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,334 | n/a |
| Dec 10, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,413 | n/a |
| Nov 25, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 947 | n/a |
| Aug 28, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 50,000 | $112.0K |
| Feb 19, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 4,000 | n/a |
| Dec 31, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,333 | n/a |
| Dec 11, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,413 | n/a |
| Nov 25, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/Award | 23,248 | n/a |
| Aug 23, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 15,000 | $60.1K |